. The guideline adherence of treatment in low risk patients was 75%, which is comparable with reports of 60% (2) and 76.8% (3) in similar studies. However, 25% of low risk patients received anticoagulation therapies, which is an overtreatment (Fig. 1) . In intermediate risk patients, 64.3% received guideline adherent therapies, which is similar to reports of 64.8% (5) and 54.2% (6) in litera-ture. However, double anticoagulation therapy was seen in 25.7% of patients, which was considered as overtreatment. In high-risk group of patients, guideline adherence was seen only in 31% of patients, similar to reports in literature (6) . The contraindication of warfarin was not present in any of 7 (24.2%) patients receiving aspirin in highrisk group patients, thus these patients were considered to be undertreated. Surprisingly, 44.8% of patients in high-risk group were prescribed with double anticoagulation. This rate of overtreatment was significantly higher than 6% in literature (6). Previous studies have shown that double anticoagulation does not benefit patients with lowering stroke risk; rather double anticoagulation increases the chance of adverse effects including bleeding events (7). However, 25.2% (31/123) of all patients in this study were prescribed with both antiplatelet and anticoagulant medication. Although strong evidences support the use of anticoagulants in accordance to guidelines in practice, the physicians are not generally treating patients with AF in an evidence-based manner. The study represented the low adherence of Iranian physicians in treatment of AF patients to current suggested guideline for prevention of stroke. The results were in line with the available literature of developed and developing countries. However, an overtreatment of patients was seen in the study, which is rarely seen in the literature. It seems that physicians are prescribing medications to patients with AF irrespective to stroke risk assessment tools. This finding necessitates the need for another study to assess the complications of anticoagulants in AF patients in Tehran, Iran. Although the results of this study are of universityaffiliated hospitals, similar pattern of practice is expected in other health care service providers (8) . 
